Skip to main content
Premium Trial:

Request an Annual Quote

Tamir Kazaz, Mark Smedley

Premium
Rosetta Genomics said this week that its CFO Tamir Kazaz has resigned to “pursue other interests.”
 
According to the company, a search has begun to find a replacement for Kazaz, who is expected to leave in the second half of 2008.
 

 
Invitrogen announced that Mark Smedley, the firm’s global head of operations, will lead the integration team for its $6.7 billion acquisition of Applied Biosystems.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.